Development of an oral formulation for oestrone-3-O-sulphamate, a potent sulphatase inhibitor

Ulrike G. Sahm; G. J. Williams; Atul Purohit; M. Isabel Hidalgo Aragones; D. Parish; M. J. Reed; Barry V. L. Potter; Colin W. Pouton

doi:10.1111/j.2042-7158.1996.tb00524.x

Development of an oral formulation for oestrone-3-O-sulphamate, a potent sulphatase inhibitor

Ulrike G. Sahm, G. J. Williams, Atul Purohit, M. Isabel Hidalgo Aragones, D. Parish, M. J. Reed, Barry V. L. Potter, Colin W. Pouton

Department of Life Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	17-20
Journal	Pharmacy and Pharmacology Communications
Volume	2
Issue number	1
DOIs	https://doi.org/10.1111/j.2042-7158.1996.tb00524.x
Publication status	Published - Jan 1996

Access to Document

10.1111/j.2042-7158.1996.tb00524.x

Cite this

@article{7bc32af1d088471794b59fb26358f0bf,

title = "Development of an oral formulation for oestrone-3-O-sulphamate, a potent sulphatase inhibitor",

author = "Sahm, {Ulrike G.} and Williams, {G. J.} and Atul Purohit and {Hidalgo Aragones}, {M. Isabel} and D. Parish and Reed, {M. J.} and Potter, {Barry V. L.} and Pouton, {Colin W.}",

year = "1996",

month = jan,

doi = "10.1111/j.2042-7158.1996.tb00524.x",

language = "English",

volume = "2",

pages = "17--20",

journal = "Pharmacy and Pharmacology Communications",

issn = "2042-7158",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Development of an oral formulation for oestrone-3-O-sulphamate, a potent sulphatase inhibitor

AU - Sahm, Ulrike G.

AU - Williams, G. J.

AU - Purohit, Atul

AU - Hidalgo Aragones, M. Isabel

AU - Parish, D.

AU - Reed, M. J.

AU - Potter, Barry V. L.

AU - Pouton, Colin W.

PY - 1996/1

Y1 - 1996/1

UR - http://dx.doi.org/10.1111/j.2042-7158.1996.tb00524.x

UR - http://onlinelibrary.wiley.com/doi/10.1111/j.2042-7158.1996.tb00524.x/pdf

U2 - 10.1111/j.2042-7158.1996.tb00524.x

DO - 10.1111/j.2042-7158.1996.tb00524.x

M3 - Article

SN - 2042-7158

VL - 2

SP - 17

EP - 20

JO - Pharmacy and Pharmacology Communications

JF - Pharmacy and Pharmacology Communications

IS - 1

ER -

Development of an oral formulation for oestrone-3-O-sulphamate, a potent sulphatase inhibitor

Access to Document

Other files and links

Cite this